JP Morgan Call 540 CHTR 16.01.202.../ DE000JK63B34 /
20/06/2024 08:28:18 | Chg.- | Bid22:00:40 | Demandez à22:00:40 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.120EUR | - | - Bid taille: - |
- Ask la taille: - |
Charter Communicatio... | 540.00 - | 16/01/2026 | Call |
GlobeNewswire
09:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
08:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
07:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
07:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page